Add to Google
Date :
Time :
Advertising : Place your textual ad here - Latest News headlines : First Human Embryonic Stem Cell Lines Approved for Use Under New NIH Guidelines - PPD Launches New Global Biostatistics Technology Infrastructure - Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain -
  Print



Non-steroidal's research paper

Abstract of Non-steroidal's research paper

The recent withdrawal of rofecoxib together with new data showing that other cyclo-oxygenase-2 (COX-2) inhibitors might also be associated with an increased risk of developing adverse cardiovascular events, mainly acute myocardial infarction (MI), has created a climate of uncertainty surrounding the safety of these drugs and traditional nonsteroidal anti-inflammatory drugs (tNSAIDs) [1,2].


Access Non-steroidal's research paper
E-Mail address :
Title :
Dr Prof Mr Mrs Ms
Full name :
Job title :
Company name :
Company Size :
Country :
Area of expertise :
Request additional information :
NEW SERVICE !
pharmaceutical press release publication
PRODUCT AWARD


PERSPECTIVES



OFFICIAL PARTNERS
ICSE Partner

PMEC Partner

Bio Manufacturing Summit Partner

American Conference Institute Partner

WTP partner

NEW! Send your Press Release for publication - Related Pharmaceutical websites : Asia Manufacturing Pharma | Pharmaceutical Manufacturing News
Pharmaceutical packaging | APIs | Excipients | Generics | Processing | Outsourcing | QA/QC | Pharma Strategy | Drug Discovery | Biotechnology | Clinical Dev.
Subscribe to Asia-Lifesiences.com | Unsubscribe from Asia-Lifesiences.com | Advertise | Privacy Statement | Copyright | Contact the publisher of this site

© Intelligent Publishing Media 2009 - All rights reserved.